Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BioMarin Complied With A U.S. Department Of Justice Subpoena For Documents On Its Testing Programs For VIMIZIM And NAGLAZYME; Cannot Predict Investigation's Outcome Or Its Impact On Its Business Or Financial Statements

Author: Benzinga Newsdesk | February 26, 2024 02:52pm

https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1048477/000104847724000016/bmrn-20231231.htm

 

Posted In: BMRN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist